Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. [electronic resource]
Producer: 20150420Description: 5181-4 p. digitalISSN:- 1520-5126
- Antineoplastic Agents -- administration & dosage
- Cell Survival -- drug effects
- Cisplatin -- administration & dosage
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Nanostructures -- administration & dosage
- Organometallic Compounds -- chemistry
- Ovarian Neoplasms -- drug therapy
- Particle Size
- RNA, Small Interfering -- administration & dosage
- Surface Properties
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.